These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 668953)

  • 21. L-asparaginase (NSC-109229) plus azaserine (NSC-742) in acute lymphatic leukemia.
    Leventhal BG; Skeel RT; Yankee RA; Henderson ES
    Cancer Chemother Rep; 1970 Feb; 54(1):47-51. PubMed ID: 4945997
    [No Abstract]   [Full Text] [Related]  

  • 22. Latent onset of clinical pancreatitis in children receiving L-asparaginase therapy.
    Weetman RM; Baehner RL
    Cancer; 1974 Sep; 34(3):780-5. PubMed ID: 4527863
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of acute lymphoblastic leukemia in children with L-asparaginase].
    Russo G; Schiliro G
    Pediatria (Napoli); 1971; 79(1):27-51. PubMed ID: 5286091
    [No Abstract]   [Full Text] [Related]  

  • 24. Pancreatic panniculitis caused by L-asparaginase induced acute pancreatitis in a child with acute lymphoblastic leukemia.
    Chiewchengchol D; Wananukul S; Noppakun N
    Pediatr Dermatol; 2009; 26(1):47-9. PubMed ID: 19250405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serial sonograms to detect pancreatitis in children receiving L-asparaginase.
    Nguyen DL; Wilson DA; Engelman ED; Sexauer CL; Nitschke R
    South Med J; 1987 Sep; 80(9):1133-6. PubMed ID: 3306944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of CNS-leukaemia in children with acute leukaemia, induced either with rubidomycin or L-asparaginase.
    de Vaan GA; Marcar JR; Schretlen ED
    Padiatr Padol; 1971; 6(3):230-9. PubMed ID: 5293526
    [No Abstract]   [Full Text] [Related]  

  • 27. [L-asparaginase in the treatment of lymphoblastic leukemia in children].
    Bohlmann HG; Gallmeier WM; Göbel FJ; Stier HW
    Z Kinderheilkd; 1969; 107(2):107-14. PubMed ID: 5262681
    [No Abstract]   [Full Text] [Related]  

  • 28. Greater decrease of fibrinogen as compared to antithrombin III in L-asparaginase treated leukemia patients.
    Vicarioto M; Rosolen A; Cappellato MG; Zanesco L; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):663-9. PubMed ID: 2435632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acido-ketotic acute diabetes in a child treated by L-asparaginase].
    Aussannaire M; Cabanes J; Chaussain JL; Maria J
    Arch Fr Pediatr; 1972 May; 29(5):527-32. PubMed ID: 4632230
    [No Abstract]   [Full Text] [Related]  

  • 30. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.
    Top PC; Tissing WJ; Kuiper JW; Pieters R; van Eijck CH
    Pediatr Blood Cancer; 2005 Jan; 44(1):95-7. PubMed ID: 15368548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diabetic ketoacidosis and hypofibrinogenemia as a complication of the treatment with L-asparaginase of acute lymphoblastic leukemia].
    López Herce Cid J; Martínez A; González M; García S
    Sangre (Barc); 1986; 31(2):195-9. PubMed ID: 3088740
    [No Abstract]   [Full Text] [Related]  

  • 32. L-asparaginase-induced coagulopathy in children with acute lymphoblastic leukaemia.
    Miniero R; Saracco P; Einaudi S; Garofalo F; Lange MM; Madon E
    Drugs Exp Clin Res; 1987; 13(6):377-9. PubMed ID: 3477418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of acute leukemia with L-asparaginase.
    Loeb E; Hill JM; Hill NO; MacLellan A; Khan A; Alexander TR; Adachi A
    Recent Results Cancer Res; 1970; 33():204-18. PubMed ID: 5292717
    [No Abstract]   [Full Text] [Related]  

  • 34. Persistent diabetes and ketoacidosis due to L-asparaginase therapy.
    Varsano I; Zaizov R; Nitzan M
    Helv Paediatr Acta; 1973 Oct; 28(4):365-9. PubMed ID: 4519479
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of acute leukemias with L-asparaginase. Preliminary results].
    Jacquillat C; Weil M; Brunel-Kotschi R; Gemon MF; Levy D; Larrieu MJ; Bussel A; Tanzer J; Boiron M; Bernard J
    Med Welt; 1971 Mar; 13():503-8. PubMed ID: 5284282
    [No Abstract]   [Full Text] [Related]  

  • 36. Fatal case of L-asparaginase induced pancreatitis.
    McLean R; Martin S; Lam-Po-Tang PR
    Lancet; 1982 Dec; 2(8312):1401-2. PubMed ID: 6129490
    [No Abstract]   [Full Text] [Related]  

  • 37. [L-asparaginase in blast leukemia].
    Georgiev Z; Genova V; Avramova D
    Vutr Boles; 1973; 12(6):25-37. PubMed ID: 4522152
    [No Abstract]   [Full Text] [Related]  

  • 38. Diabetes mellitus and pancreatitis as a complication of L-asparaginase therapy.
    Charan VD; Desai N; Singh AP; Choudhry VP
    Indian Pediatr; 1993 Jun; 30(6):809-10. PubMed ID: 8132268
    [No Abstract]   [Full Text] [Related]  

  • 39. L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease.
    Haskell CM; Canellos GP; Leventhal BG; Carbone PP; Block JB; Serpick AA; Selawry OS
    N Engl J Med; 1969 Nov; 281(19):1028-34. PubMed ID: 4898857
    [No Abstract]   [Full Text] [Related]  

  • 40. Asparaginase.
    Med Lett Drugs Ther; 1978 Nov; 20(23):103-4. PubMed ID: 280748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.